{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:32:36Z","timestamp":1761129156537},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IADT"],"published-print":{"date-parts":[[2014,5,31]]},"DOI":"10.2174\/1871528113666140224103712","type":"journal-article","created":{"date-parts":[[2014,6,4]],"date-time":"2014-06-04T01:51:46Z","timestamp":1401846706000},"page":"121-127","source":"Crossref","is-referenced-by-count":20,"title":["The Risk of Progressive Multifocal Leukoencephalopathy Under Biological Agents Used in the Treatment of Chronic Inflammatory Diseases"],"prefix":"10.2174","volume":"13","author":[{"given":"Eric","family":"Toussirot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthieu","family":"Bereau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Inflammation &amp; Allergy-Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/120563","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T14:53:19Z","timestamp":1448290399000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/openurl\/content.php?genre=article&issn=1871-5281&volume=13&issue=2&spage=121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,31]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,5,31]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871528113666140224103712","relation":{},"ISSN":["1871-5281"],"issn-type":[{"value":"1871-5281","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5,31]]}}}